Market Research Logo

Global Gene Therapy Market 2018-2022

Global Gene Therapy Market 2018-2022

About Gene Therapy

Gene therapy is one of the most recent innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology and cardiovascular. It is the usage of modified gene injected into the patient’s body primarily through virus as a vector. This transmitted gene reaches the intended site to kill or treat the infected cell, thus curing the disease.
Technavio’s analysts forecast the Global Gene Therapy Market to grow at a CAGR of 22.42% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the gene therapy market. To calculate the market size, the report considers the revenue generated by the use of gene therapy across the globe.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, gene therapy market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Biogen
Gilead
Novartis
Orchard Therapeutics
Spark Therapeutics

Market driver


Market entry of novel molecules during the forecast period

For a full, detailed list, view our report

Market challenge

High treatment costs
For a full, detailed list, view our report

Market trend

Growing research in gene therapy for CVDs and orphan diseases
For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Gene Therapy Market 2018-2022

Technavio recognizes the following companies as the key players in the global gene therapy market: Biogen, Gilead, Novartis, Orchard Therapeutics, and Spark Therapeutics.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the growing research in gene therapy for CVDs and orphan diseases. The increasing prevalence of CVDs and the urgency to treat the diseases in less time is leading the major companies to move towards more effective therapies, such as gene therapy.”

According to the report, one driver influencing this market is the entry of novel molecules during the forecast period. Presently, gene therapy is one of the most advanced treatment methods in the pharmaceutical industry and there is a strong pipeline for the development of gene therapy in the forecast period.

Further, the report states that one challenge affecting this market is the high treatment costs. The competition between standard reference drug and generic drugs is intense as generics have the same therapeutic activity as the reference drug.

Companies Mentioned

Biogen
Gilead
Novartis
Orchard Therapeutics
Spark Therapeutics

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market: Global regenerative medicines market
      • Table Global regenerative medicines market segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global gene therapy market - Market size and forecast 2017-2022 ($ mn)
      • Table Global gene therapy market - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by therapy area
    • Segmentation by therapy area
      • Table Global gene therapy market - Market share by therapy area 2017-2022 (%)
    • Comparison by therapy area
      • Table Comparison by therapy area
    • Oncology - Market size and forecast 2017-2022
      • Table Global gene therapy market by oncology - Market size and forecast 2017-2022 ($ mn)
      • Table Global gene therapy oncology market - Year-over-year growth 2018-2022 (%)
    • CNS - Market size and forecast 2017-2022
      • Table Global gene therapy market by CNS - Market size and forecast 2017-2022 ($ mn)
      • Table Global gene therapy market by CNS - Year-over-year growth 2018-2022 (%)
    • Ophthalmology - Market size and forecast 2017- 2022
      • Table Global gene therapy market by ophthalmology - Market size and forecast 2017-2022 ($ mn)
      • Table Global gene therapy market by ophthalmology - Year-over-year growth 2018-2022 (%)
    • Rare diseases - Market size and forecast 2017- 2022
      • Table Global gene therapy market by rare diseases - Market size and forecast 2017-2022 ($ mn)
      • Table Global gene therapy market by rare diseases - Year-over-year growth 2018-2022 (%)
    • Others - Market size and forecast 2017-2022
      • Table Global gene therapy market by others - Market size and forecast 2017-2022 ($ mn)
      • Table Global gene therapy market by others - Year-over-year growth 2018-2022 (%)
    • Market opportunity by therapy area
      • Table Market opportunity by therapy area
  • Pipeline
    • Table Global gene therapy market pipeline: Overview
    • Table Gene therapy in pipeline: Overview
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global gene therapy market - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Gene therapy market in Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Gene therapy market in Americas - Year-over-year growth 2018-2022 (%)
    • EMEA - Market size and forecast 2017-2022
      • Table Gene therapy market in EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table Gene therapy market in EMEA - Year-over year-growth 2018-2022 (%)
    • APAC - Market size and forecast 2017-2022
      • Table Gene therapy market in APAC - Market size and forecast 2017-2022 ($ mn)
      • Table Gene therapy market in APAC - Year-over-year growth 2018-2022 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Growing research in gene therapy for CVDs and orphan diseases
    • Growing strategic alliances
    • Increasing government initiatives
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Biogen
      • Table Biogen - Overview
      • Table Biogen - Business segments
      • Table Biogen - Organizational developments
      • Table Biogen - Geographic focus
      • Table Biogen - Key offerings
      • Table Biogen - Key customers
    • Gilead
      • Table Gilead - Overview
      • Table Gilead - Business segments
      • Table Gilead - Organizational developments
      • Table Gilead - Geographic focus
      • Table Gilead - Key offerings
      • Table Gilead - Key customers
    • Novartis
      • Table Novartis: Overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
    • Orchard Therapeutics
      • Table Orchard Therapeutics - Overview
      • Table Orchard Therapeutics - Business segments
      • Table Orchard Therapeutics - Organizational developments
      • Table Orchard Therapeutics - Key offerings
      • Table Orchard Therapeutics - Key customers
    • Spark Therapeutics
      • Table Spark Therapeutics - Overview
      • Table Spark Therapeutics - Business segments
      • Table Spark Therapeutics - Organizational developments
      • Table Spark Therapeutics - Key offerings
      • Table Spark Therapeutics - Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report